#United States #New York #Abbott #HSS Medical Supply #ID NOW

HSS Medical Supply and Abbott Collaboration: A New Era in Rapid Testing

In a significant step towards improving healthcare diagnostics, HSS Medical Supply has recently announced a new distributor agreement with Abbott, one of the global leaders in rapid point-of-care diagnostics. This partnership brings Abbott's innovative ID NOW™ rapid molecular testing platform into HSS Medical Supply’s extensive catalog of over 2,000 medical products. The integration of this advanced testing solution not only enhances the array of point-of-care offerings available to healthcare providers but also emphasizes the role of swift and precise diagnostics in current medical practices.

What is the Abbott ID NOW Platform?

The ID NOW™ platform by Abbott is a cutting-edge instrument-based molecular testing system designed to detect a variety of infectious diseases efficiently. It is tailored for use in clinics, physician offices, urgent care centers, and outpatient settings with the necessary certification. Notably compact and user-friendly, this benchtop instrument boasts capabilities that enable healthcare professionals to receive lab-grade results within a remarkably quick timeframe; for instance, it delivers results for Flu A and B, RSV, and COVID-19 in just 13 minutes or less, while providing Strep A diagnoses in under 6 minutes. Such rapid testing capabilities are vital for prompt patient management and treatment decisions.

Enhancing Diagnostic Accuracy

One of the outstanding features of the ID NOW™ platform is its molecular testing capabilities, which predominantly focus on amplifying the genetic material of the organism responsible for the infection. Unlike traditional rapid antigen tests that identify surface proteins, which may sometimes lead to lower specificity and potential false negatives, the ID NOW approach significantly reduces these inaccuracies. For example, flu diagnostic accuracy is elevated to above 96%, and antigen detection improves from somewhere between 81% to 87%. Furthermore, by eliminating the necessity for confirmatory culture tests following negative Strep A results, this platform effectively decreases the administrative burden on clinics and healthcare providers.

The implications of real-time results when patients remain in the examination room are profound: medical practitioners can initiate targeted treatment plans promptly, enhancing patient care during a single visit. Moreover, the ID NOW platform helps to combat the inappropriate prescription of antimicrobial medications by offering accurate molecular results in record time. Such advancements not only streamline operations within healthcare facilities but also support better patient experiences by minimizing callbacks and unnecessary follow-up appointments.

Financial Benefits for Healthcare Providers

In addition to its clinical advantages, the introduction of Abbott’s ID NOW platform also carries financial significance for healthcare facilities. The CPT codes associated with molecular diagnostic testing tend to attract higher reimbursement rates from major insurance payers compared to conventional rapid antigen testing codes. Hence, this transition could lead to an increase in operational revenues while simultaneously elevating the standard of care that practitioners can offer.

Peter McCann, Co-Founder of HSS Medical Supply, expressed the core mission behind this strategic partnership: “Our goal has always been to equip healthcare providers with the highest-grade tools to deliver exceptional patient care. Adding Abbott's ID NOW platform to our product portfolio allows us to offer practitioners a reliable, highly accurate diagnostic solution.” He highlighted how reducing diagnostic times and accelerating treatments can facilitate earlier patient care, which is critical in preventing the escalation of health conditions.

About HSS Medical Supply

Founded by industry veterans Peter McCann and Patrick Kiss, HSS Medical Supply is a family-owned business dedicated to providing top-tier medical distribution services. Officially launching operations in November 2025, the company prides itself on offering competitive pricing across a range of medical supplies, equipment, and pharmaceuticals. Boasting a robust inventory of over 20,000 products, HSS Medical Supply serves healthcare institutions throughout New York, Massachusetts, North Carolina, and New Jersey. With their commitment to exceptional service and reliable supply chains, HSS Medical Supply is poised to significantly impact the healthcare landscape by enhancing the accessibility of advanced medical tools and solutions.

For more information or to explore their extensive catalogue, interested healthcare providers can visit the HSS Medical Supply website or contact them directly at +1 (833) 477-1001.